Skip to main content
. 2021 Nov 24;6(6):e00685-21. doi: 10.1128/mSphere.00685-21

FIG 1.

FIG 1

Epidemiological surveillance and serologic diagnostics of SARS-CoV-2 from San Martin, Peru. (A) Mean altitude (meters above sea level) map of Peru. The department of San Martin is circled in black. (B) Number of confirmed cases in San Martin as of June 2021. The times where incidence data and samples for the serologic study were taken are marked with arrows. Surveillance data were gathered from https://diressanmartin.gob.pe/ and https://www.gob.pe/minsa/. Reactivity of serum samples from SARS-CoV-2 seroprevalence study in San Martin in 2021 (C) and pre-COVID-19 samples from 2013 to 2018 from Peru (D) in a chemiluminescence immunoassay (CLIA), shown in the x axis, and a SARS-CoV-2 surrogate virus neutralization test (sVNT), shown in the y axis. AU/ml, absorbance unit per milliliter.